160 related articles for article (PubMed ID: 2045026)
41. Interaction of ACTH, corticosterone and cyclic nucleotides in Harding-Passey melanoma melanogenesis.
Abramowitz J; Chavin W
Arch Dermatol Res; 1978 May; 261(3):303-9. PubMed ID: 210723
[TBL] [Abstract][Full Text] [Related]
42. Characterization of human malignant melanoma cell lines. IV. Cytologic and histochemical characteristics.
Qizilbash AH; Liao SK; Dent PB
Acta Cytol; 1977; 21(1):147-50. PubMed ID: 65091
[TBL] [Abstract][Full Text] [Related]
43. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
[TBL] [Abstract][Full Text] [Related]
44. Selective localization of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in B 16 melanoma.
Shoemaker DD; Legha SS; Cysyk RL
Pharmacology; 1978; 16(4):221-5. PubMed ID: 204948
[TBL] [Abstract][Full Text] [Related]
45. Production of specific macrophage activating factor by lymphocytes from tumor-bearing mice.
Kripke ML; Budmen MB; Fidler IJ
Cell Immunol; 1977 May; 30(2):341-52. PubMed ID: 67910
[No Abstract] [Full Text] [Related]
46. Gastrointestinal cancer studies in the human to nude mouse heterotransplant system.
Schmidt M; Deschner EE; Thaler HT; Clements L; Good RA
Gastroenterology; 1977 May; 72(5 Pt 1):829-37. PubMed ID: 321290
[TBL] [Abstract][Full Text] [Related]
47. AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.
Carey TE; Lloyd KO; Takahashi T; Travassos LR; Old LJ
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2898-902. PubMed ID: 313568
[TBL] [Abstract][Full Text] [Related]
48. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 Feb; 35(2):171-9. PubMed ID: 312169
[TBL] [Abstract][Full Text] [Related]
49. [Cytogenetic characteristics of transplantable mouse tumors].
Kuznetsova LE; Samsonova LI
Vopr Onkol; 1979; 25(11):54-7. PubMed ID: 293090
[TBL] [Abstract][Full Text] [Related]
50. Cryosurgical and thermal monitoring system for management of malignancy.
Najjar TA; Wilchins S; Levy M; Hrycak P
Oral Surg Oral Med Oral Pathol; 1979 Feb; 47(2):114-9. PubMed ID: 284272
[TBL] [Abstract][Full Text] [Related]
51. Secondary malignant melanoma in lymph nodes: incidence, time of occurrence, and mortality.
Little JH; Davis NC
Aust N Z J Surg; 1978 Feb; 48(1):9-13. PubMed ID: 276355
[TBL] [Abstract][Full Text] [Related]
52. Nerve growth factor receptors on human melanoma cells in culture.
Fabricant RN; De Larco JE; Todaro GJ
Proc Natl Acad Sci U S A; 1977 Feb; 74(2):565-9. PubMed ID: 265522
[TBL] [Abstract][Full Text] [Related]
53. Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition.
Niles RM; Logue MP
J Supramol Struct; 1979; 11(2):251-8. PubMed ID: 232892
[TBL] [Abstract][Full Text] [Related]
54. Tumor imaging with x-rays using macrophage uptake of radiopaque fluorocarbon emulsions.
Long DM; Multer FK; Greenburg AG; Peskin GW; Lasser EC; Wickham WG; Sharts CM
Surgery; 1978 Jul; 84(1):104-12. PubMed ID: 208188
[TBL] [Abstract][Full Text] [Related]
55. Diffuse melanosis and trichochromuria in malignant melanoma.
Agrup G; Agrup P; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1979; 59(5):456-7. PubMed ID: 93371
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents.
Bellet RE; Danna V; Mastrangelo MJ; Berd D
J Natl Cancer Inst; 1979 Nov; 63(5):1185-8. PubMed ID: 91697
[TBL] [Abstract][Full Text] [Related]
57. Cytostatic treatment of meningeal blastoses.
Engelhardt P; Lorenz R
J Neurol; 1979 Jan; 220(4):279-89. PubMed ID: 90137
[TBL] [Abstract][Full Text] [Related]
58. [Artificial heterogenization of tumors].
Gamburg GV
Vopr Onkol; 1976; 22(7):103-11. PubMed ID: 63180
[No Abstract] [Full Text] [Related]
59. Effects of antineoplastic agents on wound healing in mice.
Cohen SC; Gabelnick HL; Johnson RK; Goldin A
Surgery; 1975 Aug; 78(2):238-44. PubMed ID: 50629
[TBL] [Abstract][Full Text] [Related]
60. PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
Lee TH; Lee MS
Biochim Biophys Acta; 1976 Aug; 444(1):181-91. PubMed ID: 8131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
